Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Trusted resource of information on Nuclear Medicine that includes articles, news, diet & nutrition, multimedia presentations, ...

Meritus Medical Center has put more staff on duty to help with an increase in patients in the wake of Frederick Health's ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

GSK was able to offset the decline thanks to a better-than-expected performance for its cancer medicines and HIV therapeutics ...

Children's Hospital Los Angeles has reportedly paused the initiation of hormone therapy for new transgender youth patients.

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...

This had never happened before. There is a remarkable story behind these cells; it's more than half a century old, but still relevant and current. Dr Maninder Ahluwalia, senior lecturer in ...